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Abstract
Background Reactive oxygen species (ROS) cause severe damage to extracellular matrix and to molecular
structure of DNA, proteins and lipids. Accumulation of these molecular changes apparently constitutes the basis of
cell ageing. 17b-estradiol (E2) has a key role in skin ageing homeostasis as evidenced by the accelerated decline in
skin appearance seen in the perimenopausal years. Oestrogens improve many aspects of the skin such as skin
thickness, vascularization, collagen content and quality. Despite these clinical evidences, the effects of oestrogens
on skin at the cellular level need further clarification.
Materials and Methods HaCaT and human fibroblasts were cultured under various conditions with E2 and H2O2;
then were subjected to immunofluorescence and western blot analysis. Lipoperoxidation was investigated using
BODIPY.
Results In human fibroblasts oxidative stress decreases procollagen-I synthesis, while E2 significantly increases it.
Fibroblasts and HaCaT cells viability in the presence of E2 demonstrates a notably increased resistance to H2O2
effects. Furthermore E2 is able to counteract H2O2-mediated lipoperoxidation and DNA oxidative damage in skin
cells.
Discussion In this study we highlight that the menopause-associated oestrogens decline is involved in reduced
collagen production and that E2 could counteract the detrimental effects of oxidative stress on the dermal
compartment during skin aging. Furthermore, our data show that physiological concentrations of oestrogens are
able to interfere with ROS-mediated cell viability reduction and to protect human skin cells against oxidative damage
to cellular membranes and nucleic acids structure.
Conclusion Our experimental data show that the presence of 17b-estradiol may protect skin cells against
oxidative damage and that the dramatic lowering of oestrogen levels during menopause, could render skin more
susceptible to oxidative damage.
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Introduction
The ageing process involves the whole body and appears visibly in
the skin. Skin ageing is influenced by several factors including
genetics, environmental exposure, hormonal changes and meta-
bolic processes. These factors together lead to cumulative altera-
tions of skin structure, function and appearance. Clinical signs of
natural ageing include fine wrinkles and skin laxity while photo-
aged skin appears dry, with coarse wrinkles and uneven pigmenta-
tion. However, both processes share common features such as
reduced collagen levels in the dermis resulting from decreased pro-
collagen synthesis and increased collagen degradation.1 Collagen-I
is the major structural protein of the dermis and provides strength
and resiliency to the skin. Collagen-I is primarily produced by der-
mal fibroblasts and is regulated by a variety of mediators including
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growth factors, cytokines, hormones and mechanical tension.2 In
aged skin, a dramatic decrease in procollagen synthesis by fibro-
blasts is evident.3 The decrease of oestrogens during menopause is
associated with increased skin dryness4 and decreased skin elastic-
ity,5 dermal thickness6 and skin collagen content.7
Various studies have shown that oestrogen therapy (ET)
improve skin hydration8 and elasticity,9 higher density of collagen
fibres,10,11 fewer wrinkles12,13 and thicker skin.14 Although many
evidences highlighted the beneficial effects of oestrogen on skin,
some studies did not show remarkable improvements with
ET.15,16 Thus, the effects of oestrogens on skin are somewhat
controversial and still need further evaluations.17
Oxidative stress (OS) is considered a primary feature in driving
the ageing process. Ageing has been considered the consequence of
free radical damage by various endogenous reactive oxygen species
(ROS), according to the original free radical theory of ageing.18,19
ROS form as a natural by-product of the normal cellular metabo-
lism and have important roles in cell signalling and homeostasis.
ROS production and release can be influenced by environmental
factors such as UV radiation and exogenous toxins (i.e. nitric
oxide and cigarette smoke). Key ROS include superoxide (dO2
-),
hydroxyl radical (dOH) and hydrogen peroxide (H2O2). Increased
ROS can overwhelm antioxidant defences causing damage to
DNA (mutations ⁄breaks), proteins (nitrotyrosinylation), lipids
(peroxidation) and sugars.20–22 Oxidative damage can compro-
mise cell survival,23,24 proliferation,24–26 differentiation24,27,28 and
metabolism.29–31 Long-term effects of oxidative damage are impli-
cated in skin ageing, cancer32 and inflammation.33 In particular, in
photodamaged and chronologically aged human skin, the
increased OS leads to the induction of AP-1 and NF-jB transcrip-
tion factors,1,34 which consequently induce collagen degradation
by matrix metalloproteinases (MMPs) upregulation.1,35 These data
have been confirmed in different experimental models.1,34,35
Many data indicate that, in nervous and cardiovascular systems,
oestrogens act as antioxidant,36,37 providing a protective mecha-
nism against ROS-induced oxidative damage. These data may be
extrapolated to the hypothesis that 17b-estradiol (E2) could exert
similar beneficial effects in human skin.
Materials and methods
Materials
Phenol red-free Dulbecco’s modified Eagle’s medium (PRF-
DMEM) and phosphate buffered saline (PBS) were from Gibco
(Milan, Italy). Bicinchoninic acid (BCA) protein assay was from
Pierce (Rockford, IL, USA). Horseradish peroxidase (HRP)-
conjugated anti-mouse antibody was from Millipore (Milan, Italy).
Mouse monoclonal antibody against 8-hydroxy-2’-deoxyguano-
sine (8-OHdG), mouse monoclonal antibody against procollagen-
I a2 and mouse monoclonal antibody against b-actin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Alexa Fluor 488-conjugated anti-mouse was from Molecu-
lar Probes (Eugene, OR, USA). BODIPY fluorescent probe was
from Invitrogen (Milan, Italy). Unless otherwise specified, all other
chemicals were from Sigma-Aldrich (Milan, Italy).
Cell culture
Normal human skin fibroblast cultures were established from a
punch biopsy obtained from healthy female donors undergoing
routine minor elective surgery. Briefly, skin specimens were cut
into 1-mm2 sections and incubated for 1 h in a 5% CO2
atmosphere at 37 C in DMEM supplemented with dispase to
facilitate separation of the epidermis from the dermis. Human
dermal fibroblasts were obtained from explant cultures of the de-
epidermized dermis. Fibroblast cultures derived from three healthy
donors were polled and maintained in PRF-DMEM supplemented
with 10% fetal bovine serum (FBS), 100 units ⁄mL penicillin and
100 lg ⁄mL streptomycin (P ⁄ S). The immortalized human kerati-
nocytes cell line HaCaT was kindly provided by Dr. V. Barygina
(Department of Biochemical Sciences, University of Florence, Flor-
ence, Italy) and was cultured under the same conditions. For all
experiments, cells were grown to 80% confluence and serum
starved for 24 h before treatment.
Immunofluorescence analysis
Dermal fibroblasts and HaCaT keratinocytes (1 · 106) were
seeded onto glass slides and incubated in a 5% CO2 atmosphere at
37 C in PRF-DMEM supplemented with 10% FBS and 1% P ⁄ S.
After 24 h, the medium was changed to PRF-DMEM without
FBS, supplemented with 1% P ⁄ S. Cells were treated with E2
(1 nM) solubilized in absolute ethanol or with vehicle control for
48 h, then washed twice with PBS and fixed for 10 min in 3.7%
paraformaldehyde (PFA). After three washes with PBS, non-spe-
cific sites were blocked by incubating with 1% bovine serum albu-
min (BSA) at 37 C for 15 min. Cells were washed with PBS
containing 3% BSA for 30 min at room temperature (RT) and
incubated with anti-procollagen-I a2 primary antibody diluted in
PBS plus 3% BSA and 0.5% saponin, for 30 min at 37 C and
then for 1 h at 4 C. The cells were washed three times (15 min
each) in PBS plus 0.5% saponin (washing buffer) and incubated
with Alexa Fluor 488-conjugated anti-mouse secondary antibody
in washing buffer for 30 min at RT. The cells were washed three
times with PBS, dried, mounted with Fluoromount and examined
with a Zeiss Axiolab microscope (Carl Zeiss, Milan, Italy).
Western blot analysis
Human dermal fibroblasts were treated with vehicle (48 h), E2
(1 nM; 48 h), H2O2 (50 lM; 16 h). The cells were also treated for
16 h with H2O2 (50 lM) after a 48-h pretreatment with E2 (1 nM).
The cells were washed three times with ice-cold PBS, scraped off
the plates and lysed in 1 mL RIPA lysis buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1 mM Na2VO3, 1 mM NaF, 1 mM EGTA,
1 mM EDTA, 1% Nonidet P-40, 0.25% sodium deoxycholatey)
containing a protease inhibitor cocktail. The protein concentration
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was estimated by BCA assay, and equal amounts of total protein
(15 lg) from each sample were separated by SDS–PAGE and
transferred to nitrocellulose membranes. Non-specific sites were
blocked for 1 hat RT with milk powder. The membranes were
incubated overnight at 4 C with anti-procollagen-I a2 antibody.
After washing, blots were incubated with HRP-conjugated anti-
mouse antibody for 1 h at RT. After washing, blots were incubated
with peroxidase chemiluminescence substrate and signals were
detected using ChemiDoc XRS system (Bio-Rad, Milan, Italy).
Band intensities were determined by densitometric analysis (Ima-
geJ). Reprobing of the membrane with a b-actin antibody was
used to verify equal protein loading.
Mitochondrial activity assay
Mitochondrial activity was assessed by the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay in 96-well
plates. The cells were treated with increasing concentration of
H2O2 (50–250 lM), alone or in the presence of E2 (1 nM) for 24 h.
After washing with PBS, 0.5 mg ⁄mL MTT solution in
PRF-DMEM was added to the cell cultures and the samples were
incubated for 4 h at 37 C. Finally, MTT formazan crystals were
resolubilized by adding dimethylsulfoxide (DMSO) to each well.
Plates were agitated on a plate shaker for 5 min and spectrophoto-
metric absorbance at 590 nm was then determined using an ELISA
plate reader. Cell viability was expressed as a percentage of MTT
reduction.
Evaluation of lipid peroxidation
Lipid peroxidation was investigated in fibroblasts and HaCaT
using BODIPY 581 ⁄ 591, a fluorescent probe that is intrinsically
lipophilic and thus mimics the properties of natural lipids. BO-
DIPY acts as a fluorescent lipid peroxidation reporter that shifts
its fluorescence from red to green in the presence of oxidizing
agents. Briefly, cells were cultured on glass slides and treated with
vehicle (24 h), E2 (1 nM; 24 h) and H2O2 (70 lM; 16 h). The cells
were also treated with H2O2 (70 lM) for 16 h after a 24-h pretreat-
ment with E2 (1 nM). The cells were then loaded with dye by
adding BODIPY, dissolved in 0.1% DMSO (2.5 lM final concen-
tration), to the cell culture media for 30 min at 37 C. The cells
were fixed in 3.7% PFA for 10 min at RT and the BODIPY fluo-
rescence was analysed (at an excitation wavelength of 581 nm)
using a Zeiss Axiolab microscope. Moreover, lipid peroxidation
was quantified by flow cytometry. Cell suspensions were washed
twice with PBS and incubated in the dark for 30 min at 37 C
with BODIPY. Cells were washed and resuspended in PBS. Green
fluorescence and red fluorescence were revealed, respectively,
by the FL-1 (515–555 nm wavelength band) and the FL-2
(563–607 nm wavelength band) detectors of a FACScan flow
a(a)
(b)
(d)
(c)
b
a′
b′
c
c′
Figure 1 Effects of 17b-estradiol and
oxidative stress on procollagen-I synthesis.
(a–c) Immunofluorescence microscopy of
human dermal fibroblasts and HaCaT
keratinocytes immunolabeled using
anti-procollagen-I a2 antibody. (a, a’)
control fibroblasts; (b, b’) fibroblasts
treated with E2 (1 nM; 48 h); (c, c’) HaCaT.
(a–c magnification 40·; a’, b’, c’ magnifica-
tion 100·). Scale bar: 10 lM. (d) Western
blot analysis. The samples were normalized
for protein loading (15 lg) by reblotting the
membrane with a b-actin antibody. Relative
band intensities are depicted in histo-
grams. Data from three independent exper-
iments were combined and analysed by
ANOVA. *P < 0.001 vs. control, P < 0.05 vs.
control, §P < 0.001 vs. H2O2.
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cytometer (Becton Dickinson, San Jose, CA, USA) equipped with
a 15-mW argon-ion laser for excitation.
Evaluation of nucleic acids oxidation
Nucleic acid oxidation was investigated using an antibody against
8-OHdG, the most distinctive oxidative biomarker of DNA dam-
age. Human fibroblasts and HaCaT were cultured on glass slides
and treated under the same conditions described for lipid peroxi-
dation analysis. Cells were fixed for 10 min in 3.7% PFA and sub-
jected to the immunofluorescence protocol previously described.
Hoechst 33342 was used for the nuclear staining. Moreover,
nucleic acids oxidation was quantified by flow cytometry. Briefly,
the cell suspensions were washed twice with PBS and fixed in
3.7% PFA for 10 min at RT. After three washes with PBS, the
samples were incubated with the 8-OHdG antibody diluted in
0.1% Na citrate and 0.1% Triton-X100 for 1 h at 37 C. The sus-
pensions were washed twice with PBS plus 1% normal goat serum
(washing buffer), and then incubated with a FITC-conjugated
anti-mouse secondary antibody. After two washes in the washing
buffer, the cells were resuspended in PBS. Green fluorescence was
revealed by the FL-1 (515–555 nm wavelength band) detectors of
a FACScan flow cytometer equipped with a 15-mW argon-ion
laser for excitation.
Statistical analysis
All data are reported as mean ± SD of three independent experi-
ments. Statistical analysis was performed using one-way ANOVA. A
P value <0.05 was considered significant. The IC50 values were
calculated using the ALLFIT program.19
Results
Human primary dermal fibroblasts were subjected to immunoflu-
orescence and western blot analysis to investigate the role of E2
and H2O2 on procollagen-I synthesis. Figure 1a,b shows the
(a) (b)
Figure 2 Mitochondrial activity assay
performed on human dermal fibroblasts
(a) and HaCaT keratinocytes (b) treated
with increasing concentrations of H2O2
(50–250 lM) in absence or in presence of
E2 (1 nM) for 24 h. *P < 0.001 vs. H2O2.
(a)
(b)
(a′)
(b′)
Figure 3 Fluorescence microscopy and flow cytometry analysis of lipid peroxidation. (a, a’) Fluorescence microscopy analysis of
lipoperoxidation in dermal fibroblasts (a) and HaCaT (a’). BODIPY shifts its fluorescence from red to green in the presence of oxidiz-
ing agents. Merged images show an overlap of the red and green fluorescence of BODIPY. Scale bar: 20 lM. (b, b’) Quantitative
analysis of lipoperoxidation by flow cytometry in dermal fibroblasts (b) and HaCaT (b’).
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specific immunoreactivity for procollagen-I a2 observed in the
pooled cells obtained by skin dermal biopsies of three different
patients. A stronger positivity was observed in E2 (1 nM) treated
cells (Fig. 1a; panels b, b’) with respect to control cells (Fig. 1a;
panels a, a’). The specificity of staining was demonstrated through
the complete absence of labelling obtained using an isotype control
in the control samples (data not shown) and HaCaT keratinocytes
as negative control (Fig. 1c). These results, according to previous
data,7,38,39 highlight that the menopause-associated oestrogens
decline could account for the reduced collagen production. To test
the hypothesis that E2 could interfere with OS-mediated collagen
decrease, we analysed the procollagen-I expression in control and
E2 (1 nM) 48-h pretreated cells by inducing OS with H2O2 (50 lM;
12 h). Western blot analysis shown in Fig. 1d confirmed that E2
increases procollagen-I a2 expression (P < 0.001), while H2O2
decreased it (P < 0.05). Furthermore, E2 pretreatment prevented
OS-induced collagen decrease (P < 0.001) and increased collagen
content with respect to control (P < 0.001). These results support
the previous findings that ROS mediate alterations of skin
connective tissue40 and demonstrate that E2 could prevent the
ROS-induced procollagen-I synthesis decrease in human dermal
fibroblasts, suggesting a plausible protective role of E2 against
OS-mediated skin damage during ageing.
To better assess the potential protective effects of E2 against OS
in skin, we performed MTT assay on human dermal fibroblasts
and HaCaT keratinocytes (Fig. 2a,b). Fibroblasts and HaCaT were
incubated for 24 h with increasing concentrations of H2O2
(50–250 lM) in absence or in presence of E2 (1 nM). The mito-
chondrial activity measured using MTT test demonstrated a sig-
moidal relationship between cell viability and H2O2 concentration
with an IC50 of 158.9 ± 9.3 lM for fibroblasts (Fig. 2a) and of
91 ± 16 lM for HaCaT (Fig. 2b). Fibroblasts and HaCaT viability
measured in the presence of E2 1 nM demonstrated a significantly
increased resistance to H2O2 treatment, with an IC50 of
219.9 ± 3.55 lM for fibroblasts (Fig. 2a) and of 151 ± 18 lM for
HaCaT (Fig. 2b). The cells treated with E2 showed an increased
tendency to resist against H2O2 adverse effects, giving a further
demonstration of the E2 protective role against OS.
To evaluate a possible interference mechanism of oestrogen
with ROS-induced oxidative damage, we analysed the effects of E2
on H2O2-induced lipoperoxidation. Lipid peroxidation was inves-
tigated on dermal fibroblasts and HaCaT by fluorescence micros-
copy analysis using the lipophilic fluorescent probe BODIPY
(Fig. 3a,a’). The probe was not oxidized in control cells, whereas
the treatment with H2O2 (70 lM) for 16 h is capable of consider-
ably increasing the lipid peroxidation (Fig. 3a,a’). Both cellular
types were protected against H2O2-induced lipoperoxidation by a
24-h pretreatment with E2 (1 nM), which can bring the lipoperoxi-
dation rate back to comparable levels to control cells (Fig. 3a,a’).
These results were confirmed by flow cytometry analysis, as shown
(a)
(b)
(a′)
(b′)
Figure 4 Fluorescence microscopy and flow cytometry analysis of nucleic acids oxidation. (a, a’) Fluorescence microscopy analysis
of nucleic acids oxidation in human dermal fibroblasts (a) and HaCaT (a’). Oxy nucleic acids staining shows nucleic acids damage
(green). Nuclei were stained (Hoechst 33342, blue). Merged images show an overlap of 8-OHdG with Hoechst 33342. Scale bar;
10 lM. (b, b’) Quantitative analysis of nucleic acids oxidation by flow cytometry in human dermal fibroblasts (b) and HaCaT (b’).
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in Fig. 3b,b’. In both cellular types, a significant shift of H2O2 trea-
ted cells (P < 0.001, green curves) with respect to control (purple
curves) was observed. This shift is significantly reverted
(P < 0.001, vs. H2O2 treated cells) by the E2 pretreatment (pink
curves).
Nucleic acids oxidation was evaluated by immunofluorescence
microscopy analysis on dermal fibroblasts and HaCaT co-stained
with a specific anti-8OHdG antibody and Hoechst 33342
(Fig. 4a,a’). The cells treated with H2O2 (70 lM) for 16 h showed
an increased green fluorescence intensity caused by the rise of
nuclear 8-OHdG level, whereas in control cells, no significant
fluorescent signal was detected (Fig. 4a,a’). Once more the 24-h
pretreatment with E2 (1 nM) was capable of protecting both cell
types against H2O2 oxidative effects (Fig. 4a,a’). The quantitative
flow cytometry analysis confirms these results (Fig. 4b,b’). The
treatment with H2O2 induced a considerable shift of oxidized cells
(P < 0.001, green curves) with respect to control (purple curves),
whereas the E2 pretreatment (pink curves) reverted completely this
effect (P < 0.001, vs. H2O2 treated cells).
Discussion
Human skin is subject to an unavoidable intrinsic ageing process.
In addition, skin ageing is strongly influenced by exogenous
factors such as UV radiation, which may cause premature skin
ageing, also referred to as photoageing or extrinsic skin ageing.
However, both intrinsic and extrinsic processes share major
biochemical features such as reduced collagen content in the der-
mis, resulting from increased collagen degradation and decreased
procollagen synthesis.1 Oestrogens exert a profound influence on
skin, as highlighted by regressive cutaneous changes that occur
after menopause in women.7,38,41 They not only increase skin
thickness and enhance vascularization but also improve collagen
content and quality.39 Our results confirm that E2 stimulates
procollagen-I synthesis in human cultured skin fibroblasts and
highlight that the menopause-associated oestrogen decline is
involved in reduced collagen production.
OS is considered a primary driving force of the ageing
process. The free radical theory of ageing18,19 describes the pro-
gressive accumulation of damage by ROS over a lifetime as a
result of aerobic metabolism, combined with a decline in anti-
oxidant defences. ROS such as H2O2 were suggested to increase
the induction of MMPs in keratinocytes and fibroblasts,42
resulting in sustained collagen degradation and reduced
mechanical tension. Partially degraded collagen and reduced
mechanical tension of fibroblasts inhibit new procollagen syn-
thesis and lead to further production of ROS, generating a self-
perpetuating cycle, which is a critical mechanism of human
skin ageing.40,43
We tested the hypothesis that E2 could exert beneficial
effects on OS-mediated collagen decrease by western blot analy-
sis. Our results demonstrate that E2 could interfere with
ROS-induced procollagen-I synthesis decrease in human dermal
fibroblasts, counteracting the detrimental effects of OS on the
dermal compartment during skin ageing. Furthermore, our
results obtained by MTT assay clearly demonstrate that oestro-
gens are not only involved in the collagen synthesis pathway,
but could also interfere with ROS-mediated viability reduction
in human dermal fibroblasts and HaCaT keratinocytes, giving a
further demonstration of the E2 protective role against OS in
human skin.
Ageing is associated with changes in the molecular structure
of DNA, proteins and lipids - all markers of OS. Although
transient fluctuations in ROS serve important regulatory func-
tions, when present at high and ⁄or sustained levels, ROS can
cause severe damage to these molecules. Considering that an
increase in ROS levels has been observed during ageing,44 the
importance of oestrogen-related protective effects need to be
considered.
To explore the plausible protective action of E2 against
OS-induced cellular damage, we evaluated two of the major
oxidative stress markers within cells, lipoperoxidation and DNA
oxidative damage. Lipoperoxidation process proceeds by a free
radical chain reaction mechanism when the cellular peroxidized
membranes lose their permeability and integrity. DNA oxidative
damage can compromise the cellular function, and it is proba-
bly the major factor involved in mutagenesis, carcinogenesis
and ageing.45 8-OHdG induces a guanine to thymine base
transversion in DNA structure and thus is considered one of
the main biomarkers of oxidative damage. Our data show that
physiological concentrations of oestrogens are able to protect
human skin cells against oxidative damage to cellular mem-
branes and nucleic acids structure. Considering the high levels
of cutaneous ROS generated during UV exposition and also
during intrinsic ageing, our data suggested that the dramatic
lowering of oestrogen levels during menopause could make skin
more sensitive to oxidative damage caused by ROS and that
oestrogens could offer a global protection against OS by
improving cellular ability to resist against ROS damaging
effects.
Although ET has been used for many years to treat the symp-
toms of menopause and to prevent postmenopausal osteoporosis,
recent trials have reported a significant increased risk of breast
cancer and other pathologies with this treatment.46–48 For these
reasons, systemic ET cannot be recommended to treat skin ageing.
Phytoestrogens, non-steroidal plant compounds with oestrogen-
like biological activity, such as Diadzen, Genistein and Resveratrol
seem promising alternatives for skin ageing treatment. However,
the precise mechanism of action of phytoestrogens in skin is still
unknown, and their possible side-effects have not been well inves-
tigated.
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